Skip to content

Chronic Kidney Disease Japan Cohort (CKD-JAC) Study

Chronic Kidney Disease Japan Cohort (CKD-JAC) Study - Chronic Kidney Disease Japan Cohort (CKD-JAC) Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020038
Enrollment
3000
Registered
2015-12-03
Start date
2007-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

None listed

Sponsors

Kyowa Hakko Kirin Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.A broad spectrum of CKD with eGFR of 10-59 mL/min/1.73m2 2.Patients who are not scheduled dialysis initiation. 3.Patients who give a written consent for this study 4.Japanese patients living in Japan

Exclusion criteria

Exclusion criteria: 1.liver cirrhosis 2.HIV/AIDS 3.transplant recipients and patients 4.polycystic kidney disease 5.cancer

Design outcomes

Primary

MeasureTime frame
The primary outcomes are progression of CKD defined by reduction in eGFR, CVD events and all cause mortality

Secondary

MeasureTime frame
The secondary outcomes are QOL and hospitalization.

Countries

Japan

Contacts

Public ContactToru Ushigaki

Kyowa Hakko Kirin Co., Ltd. Medical Affairs

ckdjac2@kyowa-kirin.co.jp03-3282-0242

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026